lithium has been researched along with Basal Ganglia Diseases in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (84.75) | 18.7374 |
1990's | 2 (3.39) | 18.2507 |
2000's | 6 (10.17) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (1.69) | 2.80 |
Authors | Studies |
---|---|
Abedini, T; Akhondzadeh, S; Ardakani, MK; Ghannadi, F; Hosseyni, R; Moghaddam, HS; Talaei, A | 1 |
Bowden, CL; Brecher, M; Grunze, H; Jones, M; Mullen, J; Paulsson, B; Svensson, K; Vågerö, M | 1 |
Keck, PE | 1 |
Abay, E; Erdogan, E; Tuglu, C | 1 |
Henderson, VW; Wooten, GF | 1 |
Chaudhry, R; Radonjic, D; Waters, B | 1 |
Kane, JM; Kinon, B; Wegner, J; Weinhold, P; Woerner, M | 1 |
Paragas, MG | 1 |
Ayd, FJ; Settle, EC | 1 |
Sandyk, R | 1 |
Gershon, S; Kelwala, S; Pomara, N; Sitaram, N; Stanley, M | 1 |
Ford, DI; Marco, LA; Mitchell, R; Plesnarski, J; Randels, PM; Scholl, M | 1 |
Hanspal, NS; Marco, LA; Randels, PM; Robinson, B | 1 |
Lee, I; Trotter, C; Tyrer, P | 1 |
Alexander, MS; Lee, I; Regan, A; Tyrer, P | 1 |
Abrams, AA; Braff, DL | 1 |
Coulter, DM; Pillans, PI | 1 |
Book, S; McDonald, W; Muly, EC; Steffens, D | 1 |
Ghaemi, SN; Guille, C; Sachs, GS | 1 |
Benabarre, A; Colom, F; Fernández, A; Gastó, C; Herraiz, M; Martínez-Arán, A; Reinares, M; Vieta, E | 1 |
Bowden, CL; Ghaemi, SN; Grossman, F; Okamoto, A; Sachs, GS | 1 |
Gabriel, E; Karobath, M; Lenz, G | 1 |
Ananth, J | 1 |
Davydova, ON; Krendal', FP; Kudrin, AN | 1 |
Pöldinger, W | 1 |
Woggon, B | 1 |
Foerster, K; Regli, F | 1 |
Critchley, EM | 1 |
Eisdorfer, C | 1 |
Steinhart, MJ | 1 |
Appelbaum, PS; Funkenstein, HH; Hanson, MA; Shader, RI | 1 |
Thomas, CJ | 1 |
Makeeva, VL | 1 |
Kane, J; Klein, DF; Quitkin, F; Rifkin, A | 1 |
Gershon, S; Shopsin, B | 1 |
Branchey, MH; Simpson, GM | 1 |
Johnels, B; Wålinder, J; Wallin, L | 1 |
Branchey, MH; Charles, J; Simpson, GM | 1 |
Dauphinais, D; DeLisi, LE | 1 |
Gannon, MA; Hartman, ML; Murphy, DJ | 1 |
Gaffney, GR; Tune, LE | 1 |
Lawrence, JM | 1 |
Menninger, J; Miller, F; Whitcup, SM | 1 |
Weiden, P | 1 |
Chouinard, G | 1 |
Addonizio, G; Roth, SD; Stokes, PE; Stoll, PM | 1 |
Kiejna, A; Krakiewicz, A | 1 |
Yassa, R | 1 |
Munir, KM | 1 |
Sachdev, PS | 1 |
Price, WA; Zimmer, B | 1 |
Patterson, JF | 1 |
Carnrike, CL; Faulstich, ME; Williamson, DA | 1 |
Jaffe, JH; Khan, A; Morrison, B; Nelson, WH | 1 |
Aziz, N; Gracia, F; Koch, J | 1 |
Coffey, CE; Ross, DR | 1 |
Khaitan, AK; Laha, H | 1 |
Bílý, J; Hametová, M; Hanus, H; Polácková, J | 1 |
Bertolino, A; Kemali, D; Lamura, G; Longo, V; Pacini, A | 1 |
5 review(s) available for lithium and Basal Ganglia Diseases
Article | Year |
---|---|
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
Lithium adverse reactions in psychiatric patients.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Cardiovascular Diseases; Cognition Disorders; Endocrine System Diseases; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Lithium; Mental Disorders; Nervous System Diseases; Pregnancy; Seizures; Skin Diseases; Substance-Related Disorders | 1984 |
Side effects on fetus and infant of psychotropic drug use during pregnancy.
Topics: Analgesics; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Bromides; Female; Fetus; Humans; Hypnotics and Sedatives; Infant, Newborn; Infant, Newborn, Diseases; Lithium; Maternal-Fetal Exchange; Morphine Derivatives; Pregnancy; Psychotropic Drugs; Substance Withdrawal Syndrome; Time Factors; Tranquilizing Agents | 1976 |
Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Arrhythmias, Cardiac; Basal Ganglia Diseases; Brain; Diagnosis, Differential; Gastrointestinal Diseases; Humans; Lithium; Movement Disorders; Neurotransmitter Agents; Substance Withdrawal Syndrome; Substance-Related Disorders | 1985 |
Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches.
Topics: Acetylcholine; Basal Ganglia; Basal Ganglia Diseases; Behavior Therapy; Biofeedback, Psychology; Blepharospasm; Brain Stem; Diagnosis, Differential; Dyskinesia, Drug-Induced; Eyelid Diseases; Facial Nerve; Humans; Life Change Events; Lithium; Lithium Carbonate; Meige Syndrome; Oculomotor Muscles; Psychoanalytic Theory; Tetrabenazine; Trihexyphenidyl | 1985 |
8 trial(s) available for lithium and Basal Ganglia Diseases
Article | Year |
---|---|
Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial.
Topics: Amides; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Humans; Lithium; Mania; Palmitic Acids; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome | 2022 |
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Hyperprolactinemia; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome | 2005 |
Haloperidol: a quarter century of experience.
Topics: Aged; Basal Ganglia Diseases; Bipolar Disorder; Clinical Trials as Topic; Dosage Forms; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fever; Haloperidol; History, 20th Century; Humans; Kinetics; Lithium; Lithium Carbonate; Male; Mental Disorders; United States; United States Food and Drug Administration | 1983 |
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Severity of Illness Index; Treatment Outcome | 2001 |
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 2002 |
Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
Topics: Adolescent; Adult; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Oxprenolol; Tremor | 1978 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lorazepam; Parkinson Disease, Secondary; Random Allocation; Schizophrenia | 1988 |
46 other study(ies) available for lithium and Basal Ganglia Diseases
Article | Year |
---|---|
Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Delirium; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Olanzapine | 2005 |
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Body Temperature Regulation; Creatine Kinase; Fever; Haloperidol; Humans; Hypothalamus; Lithium; Male; Middle Aged; Receptors, Dopamine; Syndrome | 1981 |
Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Lithium Carbonate; Propranolol | 1982 |
A prospective study of tardive dyskinesia development: preliminary results.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Lithium; Male; Middle Aged; Prospective Studies; Risk; Time Factors | 1982 |
Oculogyric crisis induced by lithium carbonate.
Topics: Adult; Basal Ganglia Diseases; Eye Diseases; Eye Movements; Humans; Lithium; Lithium Carbonate; Male; Spasm | 1984 |
Lithium-induced accentuation of extrapyramidal symptoms in individuals with Alzheimer's disease.
Topics: Acute Disease; Aged; Alzheimer Disease; Basal Ganglia Diseases; Erythrocytes; Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged | 1984 |
Lithium and lecithin treatment in Alzheimer's disease: a pilot study.
Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Cognition; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Phosphatidylcholines; Pilot Projects | 1984 |
Possible lithium-induced extrapyramidal effects in Alzheimer's disease.
Topics: Alzheimer Disease; Basal Ganglia Diseases; Humans; Lithium; Male; Middle Aged | 1984 |
Physiological characteristics of tremor after chronic lithium therapy.
Topics: Basal Ganglia Diseases; Chronic Disease; Humans; Lithium; Lithium Carbonate; Psychotic Disorders; Tremor | 1981 |
An extrapyramidal syndrome after lithium therapy.
Topics: Aged; Basal Ganglia Diseases; Drug Synergism; Female; Humans; Lithium; Middle Aged; Orphenadrine; Tremor | 1980 |
Lithium induced cogwheel rigidity: treatment with amantadine.
Topics: Adult; Amantadine; Basal Ganglia Diseases; Bipolar Disorder; Female; Humans; Lithium | 1980 |
Fluoxetine and extrapyramidal side effects.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ganglia Diseases; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; New Zealand | 1995 |
Serotonin syndrome produced by a combination of fluoxetine and lithium.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Serotonin | 1993 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine | 1976 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cardiac Glycosides; Cats; Drug Interactions; Haloperidol; Humans; Hypertension; Lithium; Methyldopa; Methylphenidate; Monoamine Oxidase Inhibitors; Parasympatholytics; Phenothiazines; Propranolol; Tranquilizing Agents | 1977 |
[The development of psychopharmacotherapy].
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Cardiovascular System; Diagnostic Errors; Drug Interactions; Extrapyramidal Tracts; Female; Humans; Lactation; Lithium; Male; Pregnancy; Psychopharmacology; Psychotropic Drugs; Sex Factors | 1979 |
[Lithium therapy of extrapyramidal movement disorders-an attempt (author's transl)].
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Female; Humans; Huntington Disease; Lithium; Male; Middle Aged; Torticollis | 1977 |
Drug-induced neurological disease.
Topics: Anticonvulsants; Basal Ganglia Diseases; Cerebrovascular Disorders; Drug-Related Side Effects and Adverse Reactions; Humans; Lithium; Nervous System Diseases; Peripheral Nervous System Diseases; Seizures; Spinal Cord Diseases; Tranquilizing Agents | 1979 |
Observations on the psychopharmacology of the aged.
Topics: Aged; Amantadine; Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Butyrophenones; Cognition; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Dementia; Humans; Lithium; Movement Disorders; Phenothiazines; Phytotherapy; Plants, Medicinal; Propranolol; Psychotic Disorders; Psychotropic Drugs; Rauwolfia; Thiothixene | 1975 |
Practical therapeutics. Psychotropic drugs.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Barbiturates; Basal Ganglia Diseases; Benzodiazepines; Butyrophenones; Chlorpromazine; Drug Interactions; Humans; Lithium; Mental Disorders; Monoamine Oxidase Inhibitors; Propylene Glycols; Psychomotor Disorders; Psychotropic Drugs; Thioxanthenes | 1975 |
Difficulties in the clinical diagnosis of lithium toxicity.
Topics: Basal Ganglia Diseases; Cognition Disorders; Female; Humans; Lithium; Middle Aged; Movement Disorders | 1979 |
Brain damage with lithium/haloperidol.
Topics: Basal Ganglia Diseases; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Middle Aged | 1979 |
[Neurologic adverse manifestations and complications of ambulatory therapy with psychotropic drugs in the late stages].
Topics: Adult; Aged; Antidepressive Agents; Autonomic Nervous System; Basal Ganglia Diseases; Cognition Disorders; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Humans; Lithium; Male; Memory Disorders; Middle Aged; Mouth; Nervous System Diseases; Orientation; Tranquilizing Agents; Tremor | 1978 |
Extrapyramidal side effects with lithium treatment.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Schizophrenia; Tremor | 1978 |
Cogwheel rigidity related to lithium maintenance.
Topics: Adult; Affective Symptoms; Aged; Basal Ganglia Diseases; Benztropine; Bipolar Disorder; Carbonates; Female; Humans; Injections, Intravenous; Lithium; Long-Term Care; Male; Middle Aged; Time Factors | 1975 |
Cogwheel rigidity early in lithium treatment.
Topics: Basal Ganglia Diseases; Drug Interactions; Humans; Lithium; Parkinson Disease, Secondary; Time Factors; Tranquilizing Agents | 1977 |
Extrapyramidal side effects of lithium treatment.
Topics: Basal Ganglia Diseases; Female; Humans; Lithium; Male; Middle Aged; Parkinson Disease, Secondary | 1976 |
Extrapyramidal side effects in lithium maintenance therapy.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Female; Humans; Lithium; Male; Middle Aged; Muscle Rigidity; Schizophrenia | 1976 |
Neuroleptic responsiveness in siblings concordant for schizophrenia.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Humans; Lithium; Retrospective Studies; Schizophrenia | 1989 |
Extrapyramidal symptoms with addition of lithium to neuroleptics.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Drug Therapy, Combination; Humans; Lithium | 1989 |
Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Topics: Adult; Amoxapine; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzoxazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium; Middle Aged; Mood Disorders; Schizophrenia | 1985 |
Lithium-neuroleptic neurotoxicity in the elderly bipolar patient.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Cerebellar Diseases; Delirium; Drug Therapy, Combination; Humans; Lithium; Nervous System Diseases; Retrospective Studies | 1986 |
Lithium and extrapyramidal side effects of neuroleptics.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Drug Therapy, Combination; Humans; Lithium; Research Design | 1987 |
Increased extrapyramidal symptoms with addition of lithium to neuroleptics.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Drug Synergism; Female; Humans; Lithium; Male; Middle Aged | 1988 |
Neurologic complications in patients treated with lithium.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Brain Diseases; Cerebellar Diseases; Female; Humans; Lithium; Male; Seizures | 1988 |
A case of lithium-chlorpromazine interaction.
Topics: Basal Ganglia Diseases; Chlorpromazine; Confusion; Drug Interactions; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Nervous System Diseases | 1986 |
The treatment of psychotic symptoms in Fahr's disease with lithium carbonate.
Topics: Adult; Basal Ganglia Diseases; Brain; Calcinosis; Dementia; Humans; Kyphosis; Lithium; Lithium Carbonate; Male; Mood Disorders; Movement Disorders; Psychotic Disorders; Scoliosis; Tomography, X-Ray Computed | 1986 |
Lithium potentiation of neuroleptic-related extrapyramidal side effects.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lithium; Lithium Carbonate; Time Factors | 1986 |
Lithium-induced akathisia.
Topics: Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Bipolar Disorder; Female; Humans; Lithium; Lithium Carbonate; Time Factors | 1987 |
Lithium-induced akathisia.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Bipolar Disorder; Humans; Lithium; Lithium Carbonate; Male; Middle Aged | 1988 |
Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Neuroleptic Malignant Syndrome | 1985 |
Downbeat nystagmus as a side effect of lithium carbonate: case report.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Brain Diseases; Dose-Response Relationship, Drug; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Nystagmus, Pathologic; Pneumoencephalography | 1985 |
Lithium neurotoxicity in patients with degenerative brain disease.
Topics: Alzheimer Disease; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Hallucinations; Humans; Lithium; Receptors, Cholinergic; Receptors, Dopamine | 1985 |
Lithium induced extrapyramidal syndrome.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Humans; Lithium; Male | 1985 |
Rare complications in lithium therapy: two case reports.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Synergism; Female; Humans; Lithium; Movement Disorders; Remission, Spontaneous; Speech Disorders; Stomach Ulcer; Tranquilizing Agents; Voice | 1972 |
[Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
Topics: Basal Ganglia Diseases; Dihydroxyphenylalanine; Extrapyramidal Tracts; Humans; Lithium; Mental Disorders; Movement Disorders; Tranquilizing Agents | 1971 |